Internal Medicine · 2007 · 12 citations · 10 references
MedicineNephrologyPharmacologyRenal PathologyRenal PathophysiologyRheumatologyNephrotoxicity MechanismsRenal AmyloidosisRenal DiseaseRenal PharmacologyRenal ToxicityRheumatoid ArthritisAnti-inflammatory Drug ToxicologyEarly Rheumatoid ArthritisMedication-related NephrotoxicityMembranous Nephropathy TherapyNephrotoxic MedicationsNonsteroidal Anti-inflammatory Drug ToxicityRheumatoid Arthritis PharmacotherapySelective Cyclooxygenase-2 Inhibitors
Renal dysfunction and urinary abnormalities, which are usually related to drug toxicity, secondary amyloidosis, or those which overlap with other autoimmune conditions, are frequently observed in patients with rheumatoid arthritis. This is the first case report of membranous nephropathy in a patient with early-stage rheumatoid arthritis treated with the relatively selective cyclooxygenase-2 inhibitor, etodolac. The present case suggests that any kind of non-steroidal anti-inflammatory drug can cause membranous nephropathy; thus, physicians should be aware of this renal toxicity when prescribing these drugs.
10
Analysis of renal pathology and drug history in 158 Japanese patients with rheumatoid arthritis.
M Nakano, M Ueno, Shinichi Nishi et al. · PubMed · 1998 · 105 citations